Related Experiment Videos
The genetics of thin basement membrane nephropathy
Kesha Rana1, Yan Yan Wang, Mark Buzza
1Department of Medicine, University of Melbourne, Austin Health/Northern Health, The Northern Hospital, Epping, Victoria, Australia.
Seminars in Nephrology
|May 10, 2005
Summary
Thin basement membrane nephropathy (TBMN) diagnosis is evolving with genetic insights. Genetic testing for TBMN is complex, but crucial for differentiating from Alport syndrome.
Area of Science:
- Nephrology
- Genetics
- Molecular Biology
Background:
- Thin basement membrane nephropathy (TBMN) diagnosis relies on clinical and ultrastructural findings.
- Genetic underpinnings of TBMN are increasingly understood, impacting diagnostic approaches.
- TBMN shares features with carrier states of autosomal-recessive Alport syndrome.
Purpose of the Study:
- To explore the genetic basis of TBMN.
- To evaluate the role and challenges of genetic testing in TBMN diagnosis.
- To differentiate TBMN from X-linked Alport syndrome.
Main Methods:
- Analysis of clinical features and glomerular membrane ultrastructure.
- Segregation analysis of hematuria with COL4A3/COL4A4 loci in TBMN families.
- Identification and characterization of COL4A3 and COL4A4 mutations.
Main Results:
- 40% of TBMN families show hematuria linked to COL4A3/COL4A4, with identical mutations found in TBMN and Alport syndrome.
- Approximately 20 COL4A3/COL4A4 mutations identified in TBMN, primarily single nucleotide substitutions unique to each family.
- Some TBMN families with hematuria do not segregate with COL4A3/COL4A4, suggesting additional TBMN loci.
Conclusions:
- Genetic testing for TBMN via COL4A3/COL4A4 mutations is challenging due to gene size, polymorphisms, and potential new loci.
- Excluding or confirming X-linked Alport syndrome through genetic testing is more practical due to its status as a major differential diagnosis with a distinct prognosis.